Feedback needed (TLPH)
Newer to Investing (11 months in) and insider buying back in February and March for TLPH caught my eye at first. Seth Klarman, Hilary Kramer, and Joel Greenblatt describe pre-revenue biotechs like buying an option. So Talphera (previously AcelRx) is …